RxDoctor Payments Data

Steven Cook, MD

Family Medicine · Abingdon, VANPI 1689295230

Payments from drug & device makers

$296in general payments, 2019–2025

Across 11 payments — averaging $26.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$125
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$30
  • Alkermes, Inc.$30
  • Pfizer$27
  • Exact Sciences$19
  • Idorsia Pharmaceuticals US Inc$19
  • plus $46 from 3 others

What the payments were for

  • Food & beverage$296100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$296 in reported general payments places this provider in the 50th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$254,225
Medicare patients
514
Services billed
2,091

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide35$57,740
EliquisApixaban43$40,532
TrulicityDulaglutide18$24,347
MounjaroTirzepatide19$23,098
XareltoRivaroxaban18$16,858
Repatha SureclickEvolocumab11$8,154
SymbicortBudesonide/Formoterol Fumarate11$4,036
Levothyroxine Sodium201$3,361
SynthroidLevothyroxine Sodium32$2,337
Epinephrine12$2,236
Rosuvastatin Calcium156$2,214
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$2,105
Mirtazapine43$2,087
Icosapent Ethyl11$1,908
Duloxetine Hcl73$1,853

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$15$47,44537 claims
PfizerEliquis$27$40,53243 claims
AbbVieSynthroid$125$2,33732 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Abingdon

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →